News & Updates

Prisma Health says it’s developed a way to make 1 ventilator work for 4 coronavirus patients

03/28/2020

Excerpt from the article: “Prisma Health said Wednesday that it has developed a device that will allow one ventilator to be used on four patients suffering from the coronavirus. Ventilators are an important part of treating people suffering with the respiratory infection. And a shortage of ventilators has been a concern of health leaders dealing…

Read More

Code Life Ventilator Challenge

03/27/2020

Excerpt from the announcement: Montreal, Canada — March 19th, 2020 — The Montreal General Hospital Foundation, in collaboration with the Research Institute of the McGill University Health Centre (RI-MUHC), is launching a global innovation challenge, backed by a prize of $200,000 CAD. They are calling for teams to design a simple, low-cost, easy-to-manufacture and easy-to-maintain…

Read More

Assessing The Impact Of COVID-19 On Regulatory Interactions, Inspections, & Audits

03/26/2020

Excerpt from the article: By Laurie Halloran, CEO & Chairwoman of the Board, Halloran Consulting Group, Inc. While we have not yet seen any significant delays in regulatory approval of life science products to date, the impact of COVID-19 on global health authorities is continuing to evolve. We expect a variety of potential delays in…

Read More

The state of COVID-19 testing

03/26/2020

Excerpt from the article: “In these unprecedented times, we know that controlling the spread of novel coronavirus requires social distancing and testing. While all of us are doing our parts to stay at home, there’s a lot of confusion, chaos and frustration surrounding coronavirus testing in the US.  Before going further, I want to be…

Read More

AI shows high accuracy for detecting COVID-19 on CT

03/25/2020

Excerpt from the Article: A newly developed artificial intelligence (AI)-based system is highly accurate for detecting the novel coronavirus disease (COVID-19) on thoracic CT studies, according to research published online March 13 on arXiv.org. It can also quantify and track disease burden. Click the button below to read the entire article: Continue Reading The Article

Read More

AI differentiates COVID-19 from other pneumonia

03/25/2020

Excerpt from the article: “Researchers from China have developed an artificial intelligence (AI) algorithm that accurately detects COVID-19 and differentiates it from community-acquired pneumonia and other lung diseases. They shared their results in an article published online March 19 in Radiology.” Click the button below to read the entire article! Continue To The Article

Read More

Coronavirus: first person injected with trial vaccine

03/24/2020

Excerpt from the article: “The World Health Organization says that at least 20 coronavirus vaccines are currently in development in the global race for a cure. The first human trial, by the Boston-based biotech firm Moderna, is already underway. “Going from not even knowing that this virus was out there, which we then identified it…

Read More

Coronavirus (COVID-19) Update: FDA allows expanded use of devices to monitor patients’ vital signs remotely

03/24/2020

Excerpt from the article: “Today, as part of the U.S. Food and Drug Administration’s ongoing efforts to address the coronavirus outbreak (COVID-19), the agency issued a new policy that allows manufacturers of certain FDA-cleared non-invasive, vital sign-measuring devices to expand their use so that health care providers can use them to monitor patients remotely. The…

Read More

Collaboration Underway For a COVID-19 Vaccine

03/23/2020

Excerpt from the article: “As a researcher who develops vaccines for emerging infectious diseases, UConn pathobiologist and associate professor Paulo Verardi pays close attention to the news. He was doing just that in mid-January when he noticed that a new coronavirus SARS-CoV-2, causing a disease now known as coronavirus disease 2019 or COVID-19, was starting…

Read More

Coronavirus (COVID-19) Update: FDA Issues first Emergency Use Authorization for Point of Care Diagnostic

03/22/2020

Excerpt from the FDA News Release: Today, the U.S. Food and Drug Administration issued the first emergency use authorization for a point-of-care COVID-19 diagnostic for the Cepheid Xpert Xpress SARS-CoV-2 test. “The test we’re authorizing today will be able to provide Americans with results within hours, rather than days like the existing tests, and the…

Read More

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?

Archives